Tsai Kenneth Y, Tsao Hensin
Department of Dermatology, Harvard Medical School, USA.
Am J Med Genet C Semin Med Genet. 2004 Nov 15;131C(1):82-92. doi: 10.1002/ajmg.c.30037.
Recent advances in molecular genetics have led to a better understanding of the biological underpinnings of skin cancer formation. As with most cancers, the RB, p53, and RAS pathways appear to play prominent roles in the pathogenesis of several skin cancer types. Although various components of these pathways may be differentially altered in squamous cell carcinoma (SCC), basal cell carcinoma (BCC), and cutaneous melanoma, the final biochemical expression of these defects may be the same. With the unraveling of these genetic mechanisms, a more targeted approach to diagnosis and treatment may be possible in the near future.
分子遗传学的最新进展使人们对皮肤癌形成的生物学基础有了更深入的了解。与大多数癌症一样,RB、p53和RAS通路似乎在几种皮肤癌类型的发病机制中发挥着重要作用。尽管这些通路的各种成分在鳞状细胞癌(SCC)、基底细胞癌(BCC)和皮肤黑色素瘤中可能有不同程度的改变,但这些缺陷的最终生化表现可能是相同的。随着这些遗传机制的逐步揭示,在不久的将来,可能会出现更具针对性的诊断和治疗方法。